POTUS, Pandemic is over

The pandemic is over (POTUS) Emergency use authorizations August 31, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, and the Pfizer-BioNTech COVID-19 Vaccine, to authorize bivalent formulations, for use as a single booster dose Original strain BA.4 and BA.5 lineages For each bivalent COVID-19 vaccine, the FDA based its decision on the totality of available evidence, including extensive safety and effectiveness data for each of the monovalent mRNA COVID-19 vaccines, safety and immunogenicity data obtained from a clinical study of a bivalent COVID-19 vaccine that contained mRNA from omicron